Nuvectis Pharma, Inc. Reports First Quarter 2026 Financial Results and Business Highlights

Detailed price information for Nuvectis Pharma Inc (NVCT-Q) from The Globe and Mail including charting and trades.

Nuvectis Pharma, Inc. Reports 2025 Financial Results and Business Highlights

Detailed price information for Nuvectis Pharma Inc (NVCT-Q) from The Globe and Mail including charting and trades.
JD Supra

In New Exemptive Order, SEC Expands Availability of Five Business Day Tender and Exchange Offers for Non-Convertible Debt Securities

On June 30, 2026, the Division of Corporation Finance (the “Division”) of the Securities and Exchange Commission (SEC) issued an exemptive order ...

ORYZON Raises €12 Million and Signs a Financing Agreement with COFIDES to Strengthen its Balance Sheet and Accelerate its Clinical Programs

Issued 4,444,445 new ordinary shares Priced at €2.70 per share, representing a 14.15% discount on the five-day VWAP and a 12.68% discount to the ...
Taiwan News

Abivax Announces Pricing of Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares

Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural ...
TMCnet

Abivax Announces Launch of Public Offering of American Depositary Shares

Abivax Announces Launch of Public Offering of American Depositary Shares. PARIS, France – June 30, 2026 – 10:45 p.m. CEST – Abivax SA (Euronext Paris: FR0012333284 – ABVX ...